Skip to main content
Equibles

Invesco Ltd.

Position in VIR — Vir Biotechnology, Inc.

CIK 914208 Atlanta, GA
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,845,801
+$1,070,669 QoQ
Shares Held
475,545
+12.9% QoQ
Ownership
0.281%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 237 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 0% Shared 93% None 7%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. VIR ranks #83 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in VIR

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,845,801 475,545
2026-03-31 $3,775,132 421,332
2025-12-31 $2,446,357 405,698
2025-09-30 $2,386,527 417,956
2025-06-30 $2,040,452 404,852
2025-03-31 $2,628,156 405,580
2024-12-31 $2,926,984 398,772
2024-09-30 $2,967,521 396,198
2024-06-30 $3,703,252 416,096
2024-03-31 $4,547,961 448,960
2023-12-31 $2,917,568 290,017
2023-09-30 $4,268,510 455,551
2023-06-30 $10,810,785 440,717
2023-03-31 $11,525,814 495,308
2022-12-31 $12,559,478 496,226
2022-09-30 $9,754,636 505,946
2022-06-30 $12,369,758 485,660
2022-03-31 $1,033,633 40,188
2021-12-31 $7,670,624 183,201
2021-09-30 $1,523,547 35,008
2021-06-30 $1,479,390 31,290
2021-03-31 $891,994 17,398
2020-12-31 $306,309 11,438
2020-06-30 $975,249 23,804